Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Maite Martínez Aguillo"'
Autor:
Edurne Arriola, Ramón García Gómez, Pilar Diz, Margarita Majem, Maite Martínez Aguillo, Javier Valdivia, Alfredo Paredes, José Miguel Sánchez-Torres, Sergio Peralta Muñoz, Isidoro Barneto, Vanesa Gutierrez, Jesús Manuel Andrade Santiago, Francisco Aparisi, Dolores Isla, Santiago Ponce, David Vicente Baz, Angel Artal, Mariluz Amador, Mariano Provencio
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-10 (2018)
Abstract Background Although the benefit of first-line epidermal growth factor receptor (EGFR) tyrosine-kinase inhibitors (TKIs) over chemotherapy has been demonstrated in several clinical trials, data from clinical practice is lacking and the optima
Externí odkaz:
https://doaj.org/article/5d99fbd38d4248848d0a056c93027a23
Autor:
Carlos Aguado de la Rosa, Patricia Cruz Castellanos, Martín Lázaro-Quintela, Manuel Dómine, Sergio Vázquez Estévez, Guillermo López-Vivanco, José Luis Fírvida Pérez, José Luis Alonso Romero, Lioba Ferrera Delgado, Carlos García Girón, Pilar Diz Taín, Rosa Álvarez Álvarez, Pilar Mut Sanchís, Inmaculada Fernández Cantón, Isabel Manrique Abós, Maite Martínez Aguillo, Lorenzo Gómez-Aldaraví Gutiérrez, Ana Laura Ortega Granados, Ruth Álvarez Cabellos, Arancha García Sebastián, Luis Fernando García Sifuentes, Noemí Reguart
Publikováno v:
Lung Cancer. 173:83-93
To determine the incidence of ALK translocations in patients with advanced/metastatic NSCLC in Spain, to describe the clinical characteristics of these patients, and to evaluate the effectiveness and safety of treatment with crizotinib in a real-worl
Autor:
Hugo Arasanz, Miren Zuazo, Ana Bocanegra, María Gato, Maite Martínez-Aguillo, Idoia Morilla, Gonzalo Fernández, Berta Hernández, Paúl López, Nerea Alberdi, Carlos Hernández, Luisa Chocarro, Lucía Teijeira, Ruth Vera, Grazyna Kochan, David Escors
Publikováno v:
Cancers, Vol 12, Iss 2, p 344 (2020)
Hyperprogressive disease (HPD) is an adverse outcome of immunotherapy consisting of an acceleration of tumor growth associated with prompt clinical deterioration. The definitions based on radiological evaluation present important technical limitation
Externí odkaz:
https://doaj.org/article/cbbd992497834c6c9687a0e15cf4e8dd
Autor:
Hugo Arasanz, Ana Isabel Bocanegra, Idoia Morilla, Joaquín Fernández-Irigoyen, Maite Martínez-Aguillo, Lucía Teijeira, Maider Garnica, Ester Blanco, Luisa Chocarro, Karina Ausin, Miren Zuazo, Gonzalo Fernández-Hinojal, Miriam Echaide, Leticia Fernández-Rubio, Sergio Piñeiro-Hermida, Pablo Ramos, Laura Mezquita, David Escors, Ruth Vera, Grazyna Kochan
Publikováno v:
Cancers; Volume 14; Issue 16; Pages: 3846
Single-agent immunotherapy has been widely accepted as frontline treatment for advanced non-small cell lung cancer (NSCLC) with high tumor PD-L1 expression, but most patients do not respond and the mechanisms of resistance are not well known. Several
Autor:
Luisa Chocarro, Hugo Arasanz, Leticia Fernández-Rubio, Ester Blanco, Miriam Echaide, Ana Bocanegra, Lucía Teijeira, Maider Garnica, Idoia Morilla, Maite Martínez-Aguillo, Sergio Piñeiro-Hermida, Pablo Ramos, Juan José Lasarte, Ruth Vera, Grazyna Kochan, David Escors
Publikováno v:
Life
Adoptive cell therapy with genetically modified T lymphocytes that express chimeric antigen receptors (CAR-T) is one of the most promising advanced therapies for the treatment of cancer, with unprecedented outcomes in hematological malignancies. Howe
Autor:
Vanesa Gutiérrez, Angel Artal, Mariluz Amador, Javier Valdivia, Ramón García Gómez, Alfredo Paredes, Margarita Majem, Isidoro Barneto, Mariano Provencio, Dolores Isla, Jesús Manuel Andrade Santiago, Francisco Aparisi, José Miguel Sánchez-Torres, Pilar Diz, Santiago Ponce, Edurne Arriola, Sergio Peralta Muñoz, David Vicente Baz, Maite Martínez Aguillo
Publikováno v:
BMC Cancer
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
BMC CANCER
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
r-FISABIO. Repositorio Institucional de Producción Científica
Zaguán. Repositorio Digital de la Universidad de Zaragoza
BMC Cancer, Vol 18, Iss 1, Pp 1-10 (2018)
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
BMC CANCER
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
r-FISABIO. Repositorio Institucional de Producción Científica
Zaguán. Repositorio Digital de la Universidad de Zaragoza
BMC Cancer, Vol 18, Iss 1, Pp 1-10 (2018)
Background: Although the benefit of first-line epidermal growth factor receptor (EGFR) tyrosine-kinase inhibitors (TKIs) over chemotherapy has been demonstrated in several clinical trials, data from clinical practice is lacking and the optimal EGFR T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e2e0e815293fbf54e29c9b174466993
https://fundanet.fisabio.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=3122
https://fundanet.fisabio.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=3122
Autor:
Ana Manterola Burgaleta, Maite Martínez Aguillo, Ruth Vera García, Juan Ignacio Arraras Urdaniz, Esteban Salgado Pascual, Fernando Arias de la Vega
Publikováno v:
Clinical and Translational Oncology. 8:664-671
The purpose of the present work is to evaluate Quality of Life in a group of colorectal cancer patients in advanced stages of their disease, along a standard chemotherapy treatment protocol, through the EORTC core questionnaire QLQ-C30 and the colore
Autor:
Maite Martínez Aguillo, Juan Ignacio Arraras Urdaniz, Enrique Martínez López, Fernando Arias de la Vega, Ana Manterola Burgaleta, Ruth Vera García, Esteban Salgado Pascual
Publikováno v:
Clinical and Translational Oncology. 7:398-403
The objective of this study is to assess the quality of life (QoL) of two groups of patients during treatment for locally advanced head and neck (H and N) cancer.Two samples of 30 patients each in AJCC stages III and IV undergoing either of two chemo
Autor:
Maite Martínez Aguillo, M. Gutiérrez, Francisco Javier Domínguez del Valle, Enrique Martínez López, Juan José Albistur Tomé, Elena Pruja Arteaga, Juan José Valerdi Álvarez
Publikováno v:
Clinical and Translational Oncology. 6:219-223
Introduction Since the decade of the 80's, the etoposide plus cisplatinum regimen has been the standard treatment in patients with localised small-cell lung cancer (SCLC). Randomised trials have demonstrated the benefit of chemotherapy in combination
Autor:
Miguel Ángel Domínguez Domínguez, Juan Ignacio Arraras Urdaniz, Nuria Lainez Milagro, Enrique Martínez López, Maite Martínez Aguillo, Fernando Arias de la Vega, Elena Villafranca Iturre, Pilar Romero Rojano, Ana Manterola Burgaleta
Publikováno v:
Archivos Españoles de Urología (Ed. impresa) v.61 n.8 2008
SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
instname
SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
instname
Objective: The EORTC Quality of Life Group has developed a questionnaire for evaluating Quality of Life in international clinical trials: EORTC QLQ-C30, which is widely used in many countries. The purpose of this study was to assess the psychometric